首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cjc open

缩写:

ISSN:2589-790X

e-ISSN:2589-790X

IF/分区:2.1/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1248
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Nicole L Tegg,Kainat Meherali,Jenna Semmens et al. Nicole L Tegg et al.
Antiplatelet medications remain essential in managing atherosclerotic cardiovascular disease. We assessed the adequacy of female representation in the antiplatelet medication literature, which informed the 2023 Canadian Antiplatelet Guideli...
Samuel E Fineblit,David M Vickers,David J T Campbell Samuel E Fineblit
Background: Proprotein convertase subtilisin/kinase type 9 inhibitors (PCSK9is) significantly lower low-density lipoprotein cholesterol (LDL-c) level and improve cardiovascular outcomes, but they remain underutilized, pot...
Marcie J Smigorowsky,Ross T Tsuyuki Marcie J Smigorowsky
Background: Atrial fibrillation (AF) is associated with significant morbidity, mortality, and healthcare resource utilization. Health system limitations can result in delays to specialty cardiovascular (CV) care. Nurse pr...
Frederic Balen,Stephanie Louisot,Venkatesh Thiruganasambandamoorthy et al. Frederic Balen et al.
Background: Palpitations are a common reason for calling 911 or visiting the emergency department (ED). The objective of this study was to identify risk factors of a serious underlying cause of palpitations that can be ev...
Blair J MacDonald,Nathaniel M Hawkins,Fritha Munday et al. Blair J MacDonald et al.
Background: Non-physician-led models of care may improve utilization of heart failure (HF) medication therapy. Characterizing these models may help guide their implementation. ...
Mena Gewarges;CCS Heart Failure with Nonreduced Ejection Fraction (LVEF > %) Program Working Group Mena Gewarges;CCS Heart Failure with Nonreduced Ejection Fraction (LVEF > %) Program Working Group
Allie S Carew,Robin Urquhart,Megan Aston et al. Allie S Carew et al.
Background: Recent research reported that people with type 2 diabetes (T2D) and the haptoglobin (Hp) 2-2 phenotype had reduced coronary artery disease risk with aggressive glycemic targets. Those without the Hp2-2 phenoty...